about
Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric DisordersShifting from the single to the multitarget paradigm in drug discoveryBithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virusRepurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic reviewFunctional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinomaConstruction of drug network based on side effects and its application for drug repositioningKinMap: a web-based tool for interactive navigation through human kinome dataA Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug NetworkFTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse modelDiscovery of Mycobacterium tuberculosis InhA Inhibitors by Binding Sites Comparison and Ligands Prediction.Drug repurposing from the perspective of pharmaceutical companies.Polypharmacology in Precision Oncology: Current Applications and Future ProspectsData gaps limit the translational potential of preclinical research.Applications and implications of heparin and protamine in tissue engineering and regenerative medicine.Curation and analysis of multitargeting agents for polypharmacological modeling.Polypharmacology: drug discovery for the future.Recent advances in proteasome inhibitor discovery.High-throughput screening of FDA-approved drugs using oxygen biosensor plates reveals secondary mitofunctional effects.Repurposing medicinal compounds for blood cancer treatment.An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA)Proteome-wide drug screening using mass spectrometric imaging of bead-arrays.Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS.Interaction of Approved Drugs with Synaptic Vesicle Protein 2A.High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for 'Orphan' Molecules.Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.Clinical relevance of target identity and biology: implications for drug discovery and development.Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery.Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs.Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.FDA approved drugs as potential Ebola treatments.Drug-Mediated Regulation of Glycosaminoglycan Biosynthesis.Preclinical drug evaluation system in the Plasmodium knowlesi baboon model of malaria: the methotrexate study.Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case.Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review.Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections.In silico repurposing of antipsychotic drugs for Alzheimer's disease.Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory.MOLIERE: Automatic Biomedical Hypothesis Generation System.Toward drug repurposing in epigenetics: olsalazine as a hypomethylating compound active in a cellular context.
P2860
Q26748728-25D3A8E7-4311-4D5F-808D-057ED29C5962Q27144242-2AC6B6EF-79F8-4CBE-B419-B48FCC097FF9Q27468627-DA9E1279-2EE6-460B-8331-03D17A115052Q28087046-38CE4593-33D5-445D-B2F4-6F2AE061E98CQ28539182-A8D55FDA-96E8-430C-8AAB-FA2D466A602FQ28539501-F2641D1C-5906-44F8-9A24-3C86C41F3BF4Q28583683-0B5E3D8C-FB40-46FA-8256-669F020EF8AAQ28817426-FF156328-DFB2-4C95-84EC-3F577F5B4532Q29248124-F6A1C33D-894D-40E5-A30B-CEC4E9BC4685Q30396236-3D77722B-BA0B-4369-BAF5-AC73FE2FC5E8Q30400634-435CA7F4-017C-47AF-9F3B-E6EA189A49ABQ30846907-6BE958E7-3F35-44DD-B06F-720ABFCD37DFQ31035567-481FEA0F-5272-4983-BFF3-6B7FD9D28E5BQ33786769-EE40721C-7BE1-4BE6-92E7-49FE2137981DQ34222917-817A7C08-9B98-4F91-B6FB-B51864A91AD3Q34319906-3A862B4A-D8EA-4A2F-85A5-3194954AECADQ34645067-050AD738-EDCF-4381-84A7-67788289A434Q35208534-1E3CD16F-8B21-4D72-8657-0B99409D7043Q35807959-C7C67F32-5881-4EDA-B34D-8A3BA277AE4EQ35973180-84B0C08F-9813-4ED5-A57F-82DE484A187DQ36021850-46F80523-8FB3-4141-AAD0-8B3F2084DEDEQ36271413-09DC5293-9556-4344-8E05-70AE8C48364AQ36285895-BBE204F0-E97A-483D-BFB3-41D957BC9240Q36410455-E3A21EB3-4A8F-4781-8872-476855DEA61BQ37094597-DB9EA88D-7D33-4E37-835A-65E9D1CE1AF0Q37248061-918FD3F5-8EFE-4206-8E20-1B2F61D279ABQ38147723-4F16AFBD-9C07-446C-93F5-DCC763061254Q38329283-E0412FD1-3A80-4358-9507-44AE2DB0985FQ38827332-A2E6C4B6-FA70-4241-A807-5AB94E040AF9Q38939544-7ABBAC58-4ED2-4995-AE36-014626ED8AFFQ39027505-DD622F6F-F066-40DD-BA79-D201248C070EQ39060517-1BED8441-D6D9-4BED-9430-5479CFFD9E2FQ39092348-5D183348-0F34-42B6-B43E-158E132FD248Q39609944-1D0EC81E-CD2D-47EF-8EB6-C6ABCCD4D40FQ40045378-81CE506A-76E4-43E5-8ED1-3046C0577640Q41919457-5AA27C01-F8FA-4A55-9425-24239D62CA08Q42610044-D67A21D1-D627-4FEF-AC51-6A637E444908Q49886772-1AA419E9-9A3A-4C52-B2EC-6A0AF49DA38EQ50048255-A9A40DE2-C37F-44FC-A9FE-2E3CD38895DAQ51755762-F64C60FE-F5C9-42DE-BA6D-33B9A179D733
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Drug repurposing: far beyond new targets for old drugs.
@ast
Drug repurposing: far beyond new targets for old drugs.
@en
type
label
Drug repurposing: far beyond new targets for old drugs.
@ast
Drug repurposing: far beyond new targets for old drugs.
@en
prefLabel
Drug repurposing: far beyond new targets for old drugs.
@ast
Drug repurposing: far beyond new targets for old drugs.
@en
P2860
P1433
P1476
Drug repurposing: far beyond new targets for old drugs
@en
P2093
P2860
P2888
P304
P356
10.1208/S12248-012-9390-1
P407
P577
2012-07-24T00:00:00Z
P5875
P6179
1026724111